FATE THERAPEUTICS INC Quarterly Entity Common Stock, Shares Outstanding from Q3 2013 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Fate Therapeutics Inc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2013 to Q3 2024.
  • Fate Therapeutics Inc Entity Common Stock, Shares Outstanding for the quarter ending November 5, 2024 was 114M shares, a 15.5% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 114M +15.3M +15.5% Nov 5, 2024 10-Q 2024-11-12
Q2 2024 114M +15.3M +15.5% Aug 6, 2024 10-Q 2024-08-13
Q1 2024 114M +15.4M +15.7% May 2, 2024 10-Q 2024-05-09
Q3 2023 98.6M +1.43M +1.47% Oct 31, 2023 10-Q 2023-11-08
Q2 2023 98.6M +1.56M +1.61% Aug 2, 2023 10-Q 2023-08-08
Q1 2023 98.4M +1.76M +1.82% Apr 27, 2023 10-Q 2023-05-03
Q3 2022 97.2M +1.68M +1.76% Oct 27, 2022 10-Q 2022-11-03
Q2 2022 97M +1.82M +1.91% Jul 28, 2022 10-Q 2022-08-03
Q1 2022 96.6M +2.59M +2.76% Apr 28, 2022 10-Q 2022-05-04
Q3 2021 95.5M +8.25M +9.46% Oct 28, 2021 10-Q 2021-11-04
Q2 2021 95.2M +8.34M +9.6% Aug 2, 2021 10-Q 2021-08-04
Q1 2021 94M +18.1M +23.8% May 3, 2021 10-Q 2021-05-05
Q3 2020 87.2M +11.7M +15.4% Nov 3, 2020 10-Q 2020-11-05
Q2 2020 86.8M +21.5M +32.8% Aug 3, 2020 10-Q 2020-08-05
Q1 2020 75.9M +10.9M +16.8% Feb 28, 2020 10-K 2020-03-02
Q3 2019 75.6M +11.1M +17.2% Nov 4, 2019 10-Q 2019-11-05
Q2 2019 65.4M +12M +22.4% Aug 5, 2019 10-Q 2019-08-06
Q1 2019 65M +12.2M +23.2% Mar 1, 2019 10-K 2019-03-05
Q3 2018 64.5M +22.8M +54.8% Oct 30, 2018 10-Q 2018-11-01
Q2 2018 53.4M +12M +29% Aug 3, 2018 10-Q 2018-08-06
Q1 2018 52.8M +11.4M +27.5% Mar 2, 2018 10-K 2018-03-05
Q3 2017 41.7M +7.54M +22.1% Oct 31, 2017 10-Q 2017-11-01
Q2 2017 41.4M +12.5M +43.3% Aug 14, 2017 10-Q 2017-08-14
Q1 2017 41.4M +12.5M +43.4% Mar 13, 2017 10-K 2017-03-16
Q3 2016 34.1M +5.43M +18.9% Nov 4, 2016 10-Q 2016-11-07
Q2 2016 28.9M +200K +0.7% Aug 5, 2016 10-Q 2016-08-08
Q1 2016 28.9M +8.22M +39.9% Mar 2, 2016 10-K 2016-03-03
Q3 2015 28.7M +8.15M +39.6% Nov 2, 2015 10-Q 2015-11-03
Q2 2015 28.7M +8.13M +39.5% Aug 3, 2015 10-Q 2015-08-05
Q1 2015 20.6M +202K +0.99% Mar 12, 2015 10-K 2015-03-12
Q3 2014 20.6M +212K +1.04% Nov 11, 2014 10-Q 2014-11-12
Q2 2014 20.6M Aug 7, 2014 10-Q 2014-08-12
Q1 2014 20.4M Mar 13, 2014 10-K 2014-03-17
Q3 2013 20.4M Nov 11, 2013 10-Q 2013-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.